Promore – Reports and prospectus

Interim Reports (Promore) November 23, 2018 Promore Pharma AB (publ) Delårsrapport januari – september 2018	Report (pdf)
Interim Reports (Promore) November 23, 2018 Promore Pharma AB (publ) Interim report January – September 2018	Report (pdf)
Interim Reports (Promore) August 20, 2018 Delårsrapport januari – juni 2018	Report (pdf)
Interim Reports (Promore) August 20, 2018 Interim report January – June 2018	Report (pdf)
Interim Reports (Promore) May 16, 2018 Promore Pharma AB (publ) Delårsrapport januari – mars 2018	Report (pdf)
Interim Reports (Promore) May 16, 2018 Promore Pharma AB (publ) Interim report January – March 2018	Report (pdf)
Interim Reports (Promore) February 6, 2018 Bokslutskommuniké 2017	Report (pdf)
Interim Reports (Promore) February 6, 2018 Year-end report 2017	Report (pdf)

MESSAGE FROM THE CEO

Read what our CEO has to say about our business.

Read the CEO message

BUSINESS MODEL

The RespiraSense™ business model consists of several components that together create a complete delivery that generates attractive gross margins and recurring revenues.

Learn more about the business model

VISION

To avoid preventable respiratory failure events by transforming the standard of care in patient monitoring.

MISSION

To become the de facto standard-of-care for monitoring respiratory compromised patients in Europe and the US.